Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with James Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. Here, the two discuss isotretinoin dosing and side effects.
Dermatologists practicing in the States may not routinely see leishmaniasis cases, but with global travel so common today, such tropical diseases may hitch a ride with patients into dermatologic practices throughout the U.S.
This years VirginDerm 16 is the best event to meet artists and innovators in the cosmetic world today.
Dermatologists may consider referring patients who present with body dysmorphic disorder (BDD) for mental health care and/or may consider prescribing selective serotonin reuptake inhibitors (SSRIs) for these patients. Learn more
To effectively treat pigmentary disorders in skin of color patients, dermatologists need to understand important nuances in treating the darker skin types, in order to avoid making pigmentary issues worse, says an expert. Learn more
Marketing is what fuels the success of laser practices, says Michael H. Gold, M.D., medical director of a Nashville, Tenn. laser practice with more than 40 devices.
Speaking at a session on community-based partnerships with hair stylists held during the annual meeting of the American Academy of Dermatology, dermatologists said reaching out to business professionals in the community is a means of finding African-American women who have CCCA and other forms of hair loss prevalent in African-American women earlier, when they would clearly benefit from seeing a dermatologist for treatment. Learn more
Erythematotelangiectatic rosacea, characterized by diffuse and persistent facial redness and telangiectasias, is a challenging disease to treat. Recent advances in laser and light therapies appear effective in improving these symptoms.
Research into the microbiome of the skin is advancing. A greater understanding of how the different microbes interact may lead to new treatment options for conditions like rosacea, but more questions still remain.
Survival rates for lentigo maligna (LM) melanoma-type melanomas vary. Acral lentiginous melanoma has a significantly worse survival rate than other melanoma subtypes with race appearing to play a role. Another factor may be poor awareness.
Read and learn the key element to managing ulcerated pediatric hemangiomas.
Dr. Jim Leyden, an active participant in isotretinoin's drug development process, discusses many of the important initial clinical observations and those that others have made over the years.
Hormonal therapy is effective in treating acne, but patients will likely have to remain on hormonal therapy long-term to maintain the benefits.
Treating troublesome IH early can help avoid or minimize complications, but complex requirements demand that physicians and parents cultivate strong relationships and effective communication.
Vitamin B3 derivatives provide numerous anti-aging benefits. Learn more
Ask your patients about their use of alternative/complementary therapies, which are often helpful but can cause or worsen skin problems.
Even when quality-of-care concerns prompt physicians to advocate on behalf of family members, navigating the medical system can be challenging and fraught with difficulty.
Depending on your circumstances you could save tens of thousands of dollars on your 2015 income tax bill. Lear how
Many physicians miss diagnosing hidradenitis suppurativa upon first presentation. Recognizing key traits may help physicians diagnose and begin treatment of the disease earlier.
Wrong-site surgeries do happen, but are preventable.
A 7-year-old girl is brought into the office for evaluation of eczema. On review of symptoms, her mother mentions concern about a bald spot above the daughter's right ear, noticeable when she braids her hair.
Gain an international perspective on the use of fillers and toxins, the latest advances in non-invasive techniques and technologies, and learn from a state-of-the-art practice management track that will offer business tips, marketing/branding ideas and website and social media best practices.
The way you categorize your payments may make a difference of $10,000 or more each year, every year of your career. Find out how.
Applications and nominations for several awards are being accepted now for dermatologists to receive recognition for thier work during the upcoming American Academy of Dermatology annual meeting.
Clinicians agree that multi-disciplinary teams are the optimal approach to managing advanced melanoma, for they aim for consistent messaging to patients about treatment and require that physicians who are members of the team support their therapeutic choices with evidence. However, obstacles include geographical challenges in community care, treatment sequencing and bias, and physician communication.
Dermatology Times editorial advisor Dr. Elaine Siegfried talks with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania about the art and science of isotretinoin therapy. Dr. Leyden, aside from being a member of the famed Acne Mafia, was a really active participant in the drug development process for isotretinoin, a drug for which, the institutional memory about that process may be fading. The two discuss many of the important initial clinical observations and those that others have made over the years.
Accruing and forthcoming data are being looked to for guidance on the best strategies for implementing these treatments. As valued members of the multidisciplinary care team for patients with metastatic melanoma, dermatologists should keep informed about these topics.
A recent study has shed some light on the genetic predisposition of rosacea as well as other associated environmental factors, which could lead to improved treatment and management of the disease.
Facial pigmentary disorders are a common reason why patients with skin of color seek dermatology care. Experts offer insights for establishing the diagnosis and choosing treatment.